Devmar Equities Inc

PINK:DEVM USA Shell Companies
Market Cap
$10.39K
Market Cap Rank
#51007 Global
#15721 in USA
Share Price
$0.00
Change (1 day)
+0.00%
52-Week Range
$0.00 - $0.00
All Time High
$0.23
About

DevMar Equities, Inc. engages in the real estate acquisition and development of multifamily/mixed-use and hospitality projects in urban locations with a focus in Florida. The company was formerly known as La Cortez Energy, Inc. and changed its name to DevMar Equities, Inc. in February 2019. DevMar Equities, Inc. was incorporated in 2006 and is based in Birmingham, Michigan.

Devmar Equities Inc (DEVM) - Net Assets

Latest net assets as of March 2022: $-97.88K USD

Based on the latest financial reports, Devmar Equities Inc (DEVM) has net assets worth $-97.88K USD as of March 2022.

Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($357.00) and total liabilities ($98.23K). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.

Key Net Assets Metrics

Metric Value
Current Net Assets $-97.88K
% of Total Assets -27416.53%
Annual Growth Rate N/A
5-Year Change -100.7%
10-Year Change N/A
Growth Volatility 58.26

Devmar Equities Inc - Net Assets Trend (2006–2021)

This chart illustrates how Devmar Equities Inc's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.

Annual Net Assets for Devmar Equities Inc (2006–2021)

The table below shows the annual net assets of Devmar Equities Inc from 2006 to 2021.

Year Net Assets Change
2021-12-31 $-95.15K -28.64%
2020-12-31 $-73.97K -6.40%
2019-12-31 $-69.52K -202.86%
2018-12-31 $-22.95K -100.17%
2011-12-31 $13.58 Million -34.34%
2010-12-31 $20.68 Million +963.52%
2009-12-31 $-2.39 Million -135.07%
2008-12-31 $6.83 Million +48613.85%
2007-12-31 $-14.07K -195.35%
2006-12-31 $14.76K --

Equity Component Analysis

This analysis shows how different components contribute to Devmar Equities Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

  • Retained earnings have decreased by 3960232500.0% over the analyzed period, potentially due to dividend distributions or operating losses.

Current Equity Component Breakdown (December 2021)

Component Amount Percentage
Common Stock $51.93K %
Other Comprehensive Income $-95.15K %
Other Components $39.56 Million %
Total Equity $-95.15K 100.00%

Devmar Equities Inc Competitors by Market Cap

The table below lists competitors of Devmar Equities Inc ranked by their market capitalization.

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Devmar Equities Inc's equity between the two most recent reporting periods.

Equity Growth Insights

  • From 2020 to 2021, total equity changed from -73,969 to -95,152, a change of -21,183.
  • Net loss of 21,183 reduced equity.
  • Other comprehensive income decreased equity by 21,183.
  • Other factors increased equity by 21,183.

Equity Change Factors (2020 to 2021)

Factor Impact Contribution
Net Income $-21.18K -22.26%
Other Comprehensive Income $-21.18K -22.26%
Other Changes $21.18K +22.26%
Total Change $- %

Book Value vs Market Value Analysis

This analysis compares Devmar Equities Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

Historical Price-to-Book Ratios

Date Book Value per Share Market Price P/B Ratio
2006-12-31 $0.00 $0.00 x
2007-12-31 $0.00 $0.00 x
2008-12-31 $0.39 $0.00 x
2009-12-31 $-0.11 $0.00 x
2010-12-31 $0.49 $0.00 x
2011-12-31 $0.29 $0.00 x
2019-12-31 $0.00 $0.00 x
2020-12-31 $0.00 $0.00 x
2021-12-31 $0.00 $0.00 x

Capital Efficiency Dashboard

This dashboard shows how efficiently Devmar Equities Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

  • Current Return on Equity (ROE): 0.00%
  • The company may be facing challenges in efficiently utilizing shareholder equity.
  • DuPont Analysis Breakdown:
  • • Net Profit Margin: 0.00%
  • • Asset Turnover: 0.00x
  • • Equity Multiplier: 0.00x
  • Recent ROE (0.00%) is above the historical average (-23.43%), indicating improving capital efficiency.

Historical Capital Efficiency Metrics

Year Return on Equity Net Profit Margin Asset Turnover Equity Multiplier Economic Value Added
2006 -89.69% 0.00% 0.00x 1.38x $-14.72K
2007 0.00% 0.00% 0.00x 0.00x $-27.43K
2008 -37.79% 0.00% 0.00x 1.02x $-3.26 Million
2009 0.00% -5342.74% 0.02x 0.00x $-9.90 Million
2010 -20.79% -822.03% 0.02x 1.44x $-6.37 Million
2011 -57.27% -296.22% 0.16x 1.19x $-9.13 Million
2018 -28.79% 0.00% 0.00x 1.01x $-11.18K
2019 0.00% 0.00% 0.00x 0.00x $-62.31K
2020 0.00% 0.00% 0.00x 0.00x $2.95K
2021 0.00% 0.00% 0.00x 0.00x $-11.67K

Industry Comparison

This section compares Devmar Equities Inc's net assets metrics with peer companies in the Shell Companies industry.

Industry Context

  • Industry: Shell Companies
  • Average net assets among peers: $-56,363,212
  • Average return on equity (ROE) among peers: -7.18%

Peer Company Comparison

Company Net Assets Return on Equity Debt-to-Equity Market Cap
Devmar Equities Inc (DEVM) $-97.88K -89.69% N/A $1.94
Artius II Acquisition Inc. Class A Ordinary Shares (AACB) $-60.27K 0.00% 0.00x $198.37 Million
Artius II Acquisition Inc. Units (AACBU) $-60.27K 0.00% 0.00x $205.28 Million
Ares Acquisition Corporation II (AACT-UN) $-22.04K 0.00% 0.00x $399.77 Million
AA Mission Acquisition Corp. (AAM-UN) $-559.90 Million 0.00% 0.00x $349.76 Million
Global Acquisitions Corporation (AASP) $5.32 Million -71.85% 3.84x $15.42 Million
ABV Consulting Inc (ABVN) $-185.37K 0.00% 0.00x $461.96K
Atlantic Coastal Acquisition Corp II (ACAB) $-8.52 Million 0.00% 0.00x $2.44 Million
Annabidiol Corp (ACBD) $-181.19K 0.00% 0.00x $14.73K
ACRO Biomedical Co Ltd (ACBM) $-14.79K 0.00% 0.00x $30.04K
Huaizhong Health Group Inc (ADAD) $-1.02K 0.00% 0.00x $3.15K